Beyond the Evidence: Psychological and Institutional Factors Shaping Patent Ductus Arteriosus Stent Adoption

Stephen T Dalby1,2, Daniel Fiedorek3,4, Joshua A Daily3,4

  • 1Arkansas Children'S Hospital, 1 Children's Way, Slot 512-3, Little Rock, AR, 72202, USA. SDalby2@uams.edu.

Pediatric Cardiology
|March 22, 2025
PubMed

Insights

Clinicians increasingly prefer patent ductus arteriosus (PDA) stenting over Blalock-Taussig-Thomas (BTT) shunts for infants with ductal dependent pulmonary blood flow (DDPBF). This shift is driven by psychological and institutional factors, moving beyond traditional surgical approaches.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease Management
  • Interventional Cardiology

Background:

  • Infants with ductal dependent pulmonary blood flow (DDPBF) require interventions to establish pulmonary circulation.
  • The Blalock-Taussig-Thomas (BTT) shunt has been the standard palliative procedure, but carries significant risks.
  • Patent ductus arteriosus (PDA) stenting offers a less invasive alternative.

Purpose of the Study:

  • To explore the psychological and institutional factors influencing the choice between PDA stenting and BTT shunting for DDPBF.
  • To understand the drivers behind the growing preference for PDA stenting.
  • To identify influences on clinical decision-making in pediatric cardiac interventions.

Main Methods:

  • Qualitative exploration of factors influencing procedural choice.
  • Analysis of psychological influences such as cognitive biases.
  • Examination of institutional factors including public reporting and family preferences.

Main Results:

  • Cognitive biases play a role in procedural selection.
  • Public reporting of surgical outcomes impacts clinical decisions.
  • Family preferences are increasingly considered in management choices.

Conclusions:

  • The preference for PDA stenting over BTT shunting is influenced by a complex interplay of psychological and institutional factors.
  • Understanding these influences is crucial for aligning clinical practice with evidence-based care.
  • Ensuring transparency and equity in procedural evaluation is essential for optimal patient outcomes.

Related Concept Videos